Skip to Main Content

Paper Details

Subcutaneous Atezolizumab: A Jab Without a Benefit.
Clin Pharmacol Drug Dev
2
2022
Author NameAffiliation
Mark J RatainThe University of Chicago
  • 1 - 1

Datasets

Release 1.2